Related Experiment Video

Updated: Aug 29, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Is an improved measles-mumps-rubella vaccine necessary or feasible?

Gregory J Atkins1, S Louise Cosby

  • 1Virus Group, Moyne Institute, Trinity College, Dublin 2, Ireland. Gregory.Atkins@tcd.ie

Critical Reviews in Immunology
|January 1, 2004
PubMed

Insights

The measles-mumps-rubella (MMR) vaccine is effective but linked to adverse effects. Research explores developing safer, non-replicating vaccines to maintain immunity while improving biosafety.

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • The measles-mumps-rubella (MMR) vaccine is highly effective in disease elimination and biosafety.
  • Recent controversies link the MMR vaccine to inflammatory bowel disease and autism, potentially due to its measles component.
  • A speculative hypothesis suggests the live, replicating nature of the vaccine viruses, particularly measles, may contribute to adverse effects like immunosuppression.

Purpose of the Study:

  • To address concerns regarding adverse effects associated with the live-replicating MMR vaccine.
  • To explore the development of improved, non-replicating vaccine candidates with enhanced biosafety.
  • To investigate alternative vaccine platforms for measles, mumps, and rubella.

Main Methods:

  • Review of existing literature on MMR vaccine efficacy, safety, and adverse event associations.
  • Exploration of theoretical mechanisms linking vaccine components to adverse effects.
  • Assessment of preliminary research on alternative vaccine technologies, including DNA vaccines and vector-based approaches for measles, mumps, and rubella.

Main Results:

  • While the MMR vaccine has a strong safety profile and effectiveness, some studies suggest potential associations with inflammatory bowel disease and autism, though not independently confirmed.
  • DNA vaccines for measles, mumps, and rubella have shown limited immunogenicity in animal models.
  • Alternative vaccine strategies, such as using the rubella virus as a vector, are being considered.

Conclusions:

  • Improving the biosafety of the MMR vaccine through non-replicating formulations is desirable.
  • Further research is needed to develop safe and immunogenic alternatives to the current MMR vaccine.
  • Investigating novel platforms like viral vectors may offer promising avenues for future vaccine development.

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...